Are PBMs Bad For Your Health?
Executive SummaryAll these years, drug companies thought they were the big losers in the growing influence of pharmacy benefit managers (PBMs). They saw prices erode and profits decline as a result of aggressive rebate contracting and generic substitution. The winners were consumers and payers who got more efficient care and relief from the high drug prices.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.